Schedule 13G ownership disclosure

ARCA biopharma, Inc.

Security class unavailable · CUSIP: 00211Y209

Event date: 2015-06-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,678,592
Percent of class
9.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-039125
Form type
SC 13G
Filer
Oruka Therapeutics, Inc.
CIK
CIK 907654
Filed
Jun 25, 2015
Reporting period
Jun 16, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub